1003-3734
2006 Issue 21
xi bo fen
dong zhen xiang ; ge rui zuo ; liu lan fang
dong zhen xiang ; ge rui zuo ; liu lan fang
..............page:1895-1896
Endostar
luo xing hong ; liu wu
luo xing hong ; liu wu
..............page:1893-1895
A new immunomodulatory drug lenalidomide: pharmacological activity and clinical research
SONG Li-jie;FENG Yu-fei;FU De-xing;HU Xin;WANG Wei-hong
SONG Li-jie;FENG Yu-fei;FU De-xing;HU Xin;WANG Wei-hong
..............page:1889-1892
Advances of rituximab in the treatment of malignant lymphoma
HUANG Hui-qiang;CAI Qing-qing
HUANG Hui-qiang;CAI Qing-qing
..............page:1883-1888
zi shan chun zhi yi guo xing jing shen zhang ai 2 li
zhu dong sheng ; zhang dong xiao ; zhao li na
zhu dong sheng ; zhang dong xiao ; zhao li na
..............page:1881-1882
Effects of maltose solutions for injection on the blood glucose/insulin levels and urinary glucose excretion
LI Xiao-guang;ZHAO Rong-sheng;ZHAI Suo-di;WANG Yan-rong
LI Xiao-guang;ZHAO Rong-sheng;ZHAI Suo-di;WANG Yan-rong
..............page:1878-1881
..............page:1876-1877
Preparation of adriamycin magnetic albumin nanoparticles
LIN Gen-lai;CHEN Li-ying;ZHAN Fu-gen;WANG Xiao-lin
LIN Gen-lai;CHEN Li-ying;ZHAN Fu-gen;WANG Xiao-lin
..............page:1851-1854
An improved synthetic process for gefitinib
DU Peng;PAN Chun-yue;PENG Dong-ming
DU Peng;PAN Chun-yue;PENG Dong-ming
..............page:1849-1851
Anti-tumor activity of realgar nanoparticles and the distribution of arsenic (As) in tissues of tumor-transplanted mice
XU Ling-yun;ZENG Fan-dian;YE Han-qing;YANG Xiang-liang;XU Hui-bi
XU Ling-yun;ZENG Fan-dian;YE Han-qing;YANG Xiang-liang;XU Hui-bi
..............page:1845-1849
Preparation and pharmacokinetics of paclitaxel nanometric liposomes in rats
WANG Qing-song;SHA Xian-yi;HAN Li-mei;GUO Jie;FANG Xiao-ling
WANG Qing-song;SHA Xian-yi;HAN Li-mei;GUO Jie;FANG Xiao-ling
..............page:1842-1845
Absorptions of Eb versus its HP-β-CD inclusion complex in rat gastrointestinal tract
CUI Han-ming;WU Feng-lan
CUI Han-ming;WU Feng-lan
..............page:1837-1841
Framework-reengineering and its application in humanized antibody fSM03
LIANG Rui-an;YANG Lei;CHEN Jun-xin;CHEN Han-wen;LI Zheng-dong;HUANG Pei-fen;CHEUNG Wing-tai
LIANG Rui-an;YANG Lei;CHEN Jun-xin;CHEN Han-wen;LI Zheng-dong;HUANG Pei-fen;CHEUNG Wing-tai
..............page:1832-1836
Establishment and application of a high throughput microtubule-targeted screening assay
SUN Wan;LI Min;WEI Shao-yin;WU Jun;XU Bo;CUI Jing-rong
SUN Wan;LI Min;WEI Shao-yin;WU Jun;XU Bo;CUI Jing-rong
..............page:1828-1831
Outlines of phase transformation considerations in solid oral formulations
WANG Hong;CHEN Yi-hong;LIU Gui-yang
WANG Hong;CHEN Yi-hong;LIU Gui-yang
..............page:1824-1827
Advances in research of nitric oxide-donor drugs as anticancer agents
WANG Lan;ZHAO Guang-rong;WANG Wei-dong;ZHANG Guang-ming
WANG Lan;ZHAO Guang-rong;WANG Wei-dong;ZHANG Guang-ming
..............page:1818-1823,1836
Proteasome inhibitor: anti-tumor activities and clinical application
ZHOU Yong-ming;GUO Wei;HUANG Shi-ang
ZHOU Yong-ming;GUO Wei;HUANG Shi-ang
..............page:1813-1818
Research and exploration in tumor circadian therapy
YANG Mei;TANG Zhi-qiang
YANG Mei;TANG Zhi-qiang
..............page:1807-1812
qian tan xi bao du lei kang zhong liu yao wu zhi zhi ti zhi ji de yan jiu si lu
zhang ning ; wang hai xue ; qian si yuan
zhang ning ; wang hai xue ; qian si yuan
..............page:1805-1807
yao wu mian yi du li xue shi yan fang fa de yan jiu jin zhan
wang tao ; lu guo cai ; yuan bo jun
wang tao ; lu guo cai ; yuan bo jun
..............page:1801-1804
Efficacy of Jinghuaweikang capsules in the treatment of duodenal ulcer
MA Gui-feng;HUA Jian-ping;LI Jun-mei;ZHANG Qiu-yin;BAO Wen-yi
MA Gui-feng;HUA Jian-ping;LI Jun-mei;ZHANG Qiu-yin;BAO Wen-yi
..............page:1874-1876
Effect of uroacitides injection on the function of the helper T1lymphocytes in the secretion of interleukin-2 and interferon-γin vitro
LIU Yan;ZHOU Mei-zhen;MAN Yong
LIU Yan;ZHOU Mei-zhen;MAN Yong
..............page:1870-1873
Phase Ⅰ clinical tolerance trial of elemene emulsion for injection
WANG Zi-ping;CHU Da-tong;LIU Yu-tao;LI Jun-ling;ZHAO Long-mei;ZHOU Li-qiang;ZHANG Xiang-ru
WANG Zi-ping;CHU Da-tong;LIU Yu-tao;LI Jun-ling;ZHAO Long-mei;ZHOU Li-qiang;ZHANG Xiang-ru
..............page:1867-1870
Stability evaluation of combretastatin A4 prodrug solution
MO Yi;HE Ying-ju;YAN Gen-quan;LIN Li-yang;CHEN Yan
MO Yi;HE Ying-ju;YAN Gen-quan;LIN Li-yang;CHEN Yan
..............page:1864-1866
Determination of mitoxantrone hydrochloride based on KMnO4-HCHO reaction by flow injection chemiluminescence analysis
HE Shu-hua;LI Chao-ying
HE Shu-hua;LI Chao-ying
..............page:1862-1864
Study on the inclusion complex of vanillin/cyclodextrin
GAO Jian-feng;REN Yong;WANG Xiao-jie
GAO Jian-feng;REN Yong;WANG Xiao-jie
..............page:1858-1861
Effect of matrix type and inherent viscosity on the in vitro characteristics of carboplatin-poly (lactic-co-glycolic acid) microspheres
XU Feng-hua;LIU Gui-yang;JIANG Xue-qin
XU Feng-hua;LIU Gui-yang;JIANG Xue-qin
..............page:1855-1858